Voluntary announcement - latest research results on tq-A3334 "TLR7 agonist" and bepirovirsen "aso" to be presented at 2026 aasld
Filed with HKEX · Stock code 1177 · · 3 pages · English
Sino Biopharmaceutical Limited on 6ix
Earlier from Sino Biopharmaceutical
- Next day disclosure return
- Voluntary announcement - completion of all subjects enrollment in the phase iii registrational clinical trial of TQC3721 inhalation suspension "PDE3/4 inhibitor"
- Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
- Voluntary announcement - enter into strategic biosimilars partnership with stada
- Notification letter and request form for non-registered shareholders
Follow Sino Biopharmaceutical into a list and get an email when it puts out news.
Follow Sino Biopharmaceutical